Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

NCT00823693 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Bimosiamose Cream
DRUG: Placebo Cream

Sponsor

Revotar Biopharmaceuticals AG